Post by
modulex on Dec 27, 2015 11:15am
CASH DISTRIBUTION SHOULD BE AT LEAST $0.25/SHARE
The Diagnocure-Hologic recent deal should have been long ago concluded. It took a ridiculous, wasting time for nothing to have it happened. Since Diagnocure had a significant business relationship with Gen-Probe, which was acquired by Hologic, Diagnocure was by all means entitled to know immediately upon the closing of the Hologic-Gen Probe acquisition what would go on forward with PCA3. Diagnocure made attempts in vain to sit down, hold talks with Hologic. Hologic has truly caused Diagnocure shareholders and its stock to be critically beaten-up as no action was taken. A multi-billion dollar company like Hologic is not corporately responsible when it fools around with a tiny company like Diagnocure. I dont know who is to be credited for having finally brought Hologic to put its act together and wake up but this/these person(s) deserves credit and thankfulness. Diagnocure shareholders should receive a cash distribution of at least $0.25/share as part of this deal for the troublesome behaviour displayed by Hologic in letting this matter go on for way too long delays. Since most of Diagnocure shares are held by canadian investors and the current value of the canadian dollar versus the american dollar, it would end up costing Hologic fairly cheap to pay $0.25/share to Diagnocure shareholders. $0.25 is also Diagnocure's current 52-weeks high, which therefore makes full sense to have Hologic to compensate Diagnocure shareholders to at least $0.25/share.